The authors were limited by the early termination of the trial and the use of MRI as the main imaging method, since CT is the predominant method to assess acute stroke. Benefits for patients older ...

2009 Expert Reviews Ltd. Cite this: Neuroimaging of Ischemic Stroke With CT and MRI: Advancing Towards ... but advanced imaging is not usually employed in acute stroke because of concern of ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

The following is a summary of “National Trends in Central Retinal Artery Occlusion Presentations and Stroke Workup in United ...

The following is a summary of “Incidence of Acute Kidney Injury After Exposure to Intravenous Contrast in Emergency ...

stabilize and provide emergency care to patients with acute stroke symptoms. For example, a stroke-ready hospital always has a stroke team available, has a CT scanner onsite and can administer a ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according to the manufacturer. Genentech said in a press release that TNKase ...

The AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating patients with acute ischemic stroke that presented with a disabling neurological deficit. This ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...